French Top Stock Picks from Analysts

Edenred

Market Cap: €4.2b

Operates as a digital platform for services and payments for companies, employees, and merchants worldwide.

Teleperformance

Market Cap: €3.3b

Operates as a digital business services company in France and internationally.

SEB

Market Cap: €2.7b

Designs, manufactures, and markets small domestic equipment in Western Europe, rest of Europe, the Middle East, Africa, North and South America, China, and rest of Asia.

Vusion

Market Cap: €2.4b

Engages in the provision of digitalization solutions for commerce in Europe, Asia, and North America.

Pluxee

Market Cap: €1.6b

Offers employee benefits and engagement solutions services in France, Latin America, Continental Europe, and internationally.

Ipsos

Market Cap: €1.5b

Through its subsidiaries, provides survey-based research services for companies and institutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Valneva

Market Cap: €760.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Worldline

Market Cap: €435.0m

Provides payments and transactional services for financial institutions, merchants, corporations, and government agencies in Northern Europe, Central and Eastern Europe, Southern Europe, and internationally.

STIF Société anonyme

Market Cap: €290.2m

Manufactures and sells components for the handling of bulk products in France.

Genfit

Market Cap: €262.2m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Transgene

Market Cap: €260.1m

A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

Cellectis

Market Cap: €252.4m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Groupe Pizzorno Environnement

Market Cap: €216.4m

Provides environmental services primarily in France.

Arverne Group

Market Cap: €180.6m

Produces and sells geothermal energy in France.

Bastide Le Confort Médical

Market Cap: €180.6m

Engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy.

Groupe Partouche

Market Cap: €173.1m

Through its subsidiaries, operates casinos, hotels, restaurants, dancehalls, leisure facilities, and bars in France, other European countries, and internationally.

Fountaine Pajot

Market Cap: €165.5m

Designs, develops, produces, and sells sailing catamarans, motor catamarans, and monohull for recreational boating markets internationally.

Median Technologies

Market Cap: €158.8m

Engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.

Innate Pharma

Market Cap: €138.8m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

ABIONYX Pharma

Market Cap: €131.2m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

Deezer

Market Cap: €129.8m

Provides music, lossless HiFi audio, and industry defining features on a scalable platform in France, Germany, the United Kingdom, Brazil, the United States, and internationally.

Pullup Entertainment Société anonyme

Market Cap: €124.5m

Develops, publishes, and distributes games in France, the United States, Europe, the Middle East, Africa, Asia, and internationally.

Adocia

Market Cap: €118.3m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Crossject Société Anonyme

Market Cap: €108.6m

Develops needle-free injection systems in France.

OSE Immunotherapeutics

Market Cap: €107.7m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

AB Science

Market Cap: €103.0m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

Sensorion

Market Cap: €89.8m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Reworld Media Société Anonyme

Market Cap: €85.9m

Engages in the thematic media business in France.

MaaT Pharma

Market Cap: €83.1m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Claranova

Market Cap: €81.5m

A technology company, engages in personalized e-commerce, software publishing, and Internet of Things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally.

Mexedia Società Per Azioni S.B

Market Cap: €78.7m

Engages in the provision of technologies for the telecommunications and business services sector in Italy.

AFYREN SAS

Market Cap: €76.0m

Provides biobased products to replace petroleum-based molecules in France.

Bilendi

Market Cap: €75.8m

Provides services for market research and customer engagement and loyalty services in France, United Kingdom, Germany, Switzerland, Spain, Italy, Morocco, Denmark, Sweden, Finland, Belgium, the Netherlands, and Mauritius.

Affluent Medical

Market Cap: €72.8m

A medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France.

Abéo

Market Cap: €66.6m

Engages in the design, manufacture, and distribution of sports and leisure equipment in France and internationally.

Vitura

Market Cap: €65.1m

Created in 2006, Vitura is a listed real estate company (“SIIC”) that invests in prime office properties in Paris and Greater Paris.